Table 1 The clinical information of CTEPH and control group.

From: Identification of Anoikis-related potential biomarkers and therapeutic drugs in chronic thromboembolic pulmonary hypertension via bioinformatics analysis and in vitro experiment

Group

Gender

Age

6WMT (m)

mPAP (mmHg)

PVR (Wood units)

PAWP (mmHg)

CI (min·m2)

CTEPH

Female

66

316.1

60.4

11.2

7.3

2.3

CTEPH

Female

59

308.8

56.7

13.8

11.7

1.9

CTEPH

Male

69

240.6

59

11.7

12.8

2.4

CTEPH

Male

62

317.3

64.1

9.2

10.4

2.2

CTEPH

Male

57

250.7

61.1

12.4

8.8

2.1

Control

Male

57

–

–

–

–

–

Control

Female

74

–

–

–

–

–

Control

Female

45

–

–

–

–

–

Control

Male

68

–

–

–

–

–

Control

Male

55

–

–

–

–

–

  1. 6MWT 6 Minute Walk Test, mPAP mean pulmonary arterial pressure, PVR pulmonary vascular resistance, PAWP pulmonary artery wedge pressure, CI cardiac Index.